AZU1: This is a neutrophil granule-derived antibacterial and monocyte- and fibroblast-specific chemotactic glycoprotein. Binds heparin. The cytotoxic action is limited to many species of Gram- negative bacteria; this specificity may be explained by a strong affinity of the very basic N-terminal half for the negatively charged lipopolysaccharides that are unique to the Gram-negative bacterial outer envelope. It may play a role in mediating recruitment of monocytes in the second wave of inflammation. Has antibacterial activity against the Gram-nagative bacterium P.aeruginosa, this activity is inhibited by LPS from P.aeruginosa. Acting alone, it does not have antimicrobial activity against the Gram-negative bacteria A.actinomycetemcomitans 29532, A.actinomycetemcomitans 9709, A.actinomycetemcomitans FDC-Y4, H.aphrophilus 13252, E.corrodens 23834, C.sputigena 33123, Capnocytophaga sp 33124, Capnocytophaga sp 27872 or E.coli ML-35. Has antibacterial activity against C.sputigena 33123 when acting synergistically with either elastase or cathepsin G. Belongs to the peptidase S1 family. Elastase subfamily.
Chromosomal Location of Human Ortholog: 19p13.3
Cellular Component: azurophil granule; extracellular region
Molecular Function: heparin binding; toxin binding; serine-type endopeptidase activity
Biological Process: positive regulation of tumor necrosis factor biosynthetic process; positive regulation of cell adhesion; microglial cell activation; defense response to Gram-negative bacterium; glial cell migration; proteolysis; macrophage chemotaxis; induction of positive chemotaxis; cellular extravasation; monocyte activation; positive regulation of phagocytosis; positive regulation of MHC class II biosynthetic process; positive regulation of fractalkine biosynthetic process; protein kinase C activation; positive regulation of interleukin-1 beta biosynthetic process; protein processing; immune response; regulation of vascular permeability; inflammatory response; negative regulation of apoptosis
Show more